Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10477017 | 1.00 | CA2 (0.37) | CA2 | |
| SCHEMBL28506909 | 1.00 | CA2 (0.37) | CA2 | |
| SCHEMBL10084538 | 1.00 | — | — | |
| SCHEMBL15100305 | 0.90 | — | — | |
| SCHEMBL5668460 | 0.83 | CA2 (0.44) | CA2 | |
| SCHEMBL299301 | 0.83 | CA2 (0.44) | CA2 | |
| SCHEMBL10835191 | 0.83 | CA2 (0.44) | CA2 | |
| SCHEMBL125676 | 0.83 | CA2 (0.44) | CA2 | |
| SCHEMBL11219700 | 0.83 | CA2 (0.44) | CA2 | |
| SCHEMBL23647292 | 0.83 | CA2 (0.44) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240208916-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | Amydis, Inc. | 2024-06-27 | — | — | US | disclosed |
| US-11718596-B2 | Amyloid targeting agents and methods of using the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-08-08 | — | — | US | disclosed |
| US-20210371390-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | Amydis, Inc. | 2021-12-02 | — | — | US | disclosed |
| CN-109336932-B | Amphiphilic platinum (II) complex, preparation thereof and application thereof in constructing white luminescent system | 陕西师范大学 | 2021-02-02 | — | — | CN | disclosed |
| CN-111066109-A | Redox flow batteries and compounds for battery applications | 纽约市哥伦比亚大学理事会 | 2020-04-24 | — | — | CN | disclosed |
| CN-107118761-B | White luminescent material based on amphipathic platinum complex | 陕西师范大学 | 2019-08-20 | — | — | CN | disclosed |
| CN-109336932-A | Amphipathic platinum (II) complex and its preparation and the application for constructing white luminous system | 陕西师范大学 | 2019-02-15 | — | — | CN | disclosed |
| CN-107118761-A | White luminescent material based on amphipathic platinum complex | 陕西师范大学 | 2017-09-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718596-B2 | Amyloid targeting agents and methods of using the same | APP, CRYAA, APBA1 | CA2 2917/4885 |
| US-20210371390-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | APP, CRYAA, APBA1 | CA2 2917/4885 |
| US-20240208916-A1 | AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME | APP, CRYAA, APBA1 | CA2 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.